Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 0.4171
-7.06 %
$ 12.5 M
Market Cap
-0.27
P/E
PRPH - STOCK-BASED COMPENSATION
Stock-based Compensation PRPH - ProPhase Labs, Inc.
3.54 M
LAST VALUE
5.40%
2 YEAR CAGR
41.02%
5 YEAR CAGR
29.38%
10 YEAR CAGR